Solid dispersion approach for overcoming bioavailability problems due to polymorphism of nabilone, a cannabinoid derivative

A. L. Thakkar,C. A. Hirsch,J. Page
DOI: https://doi.org/10.1111/J.2042-7158.1977.TB11468.X
1977-09-01
Abstract:The aqueous solubility of nabilone is extremely low, less than 0.5 pg ml-1 at 25". Initial pharmacological testing of nabilone was done using an aqueous colloidal suspension prepared by mixing an acetone solution of the compound with 1 % aqueous polysorbate 80 followed by removal of the acetone by evaporation. This preparation, given orally Or parenterally, elicited pronounced cns activity in dogs at very low doses. A characteristically highPited ataxia was observed approximately 2.5 h after oral dosing. Other effects noted soon thereafter included body sway, head nod, hypothermia and The maximum intensity of these effects occurred within 4 h of dosing.
What problem does this paper attempt to address?